SCHEMBL2914933

SCHEMBL2914933

COC(=O)Cc1ccc(C)c(S(=O)(=O)N2CCC3(CC2)C(=O)N(CC(C)C)C(=O)N3CCc2ccc(OC)cc2)c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
PKM P14618 1/20 0.39
ALDH1A1 P00352 5/20 0.38
MAPT P10636 4/20 0.38
HTT P42858 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GAA P10253 3/20 0.37
LMNA P02545 2/20 0.37
MMP1 P03956 2/20 0.37
MMP9 P14780 2/20 0.37
MMP13 P45452 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
RAB9A P51151 2/20 0.36
TSHR P16473 1/20 0.36
POLB P06746 1/20 0.36
KCNA5 P22460 1/20 0.35
ADAM17 P78536 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2908873 0.93 MEN1 (0.37) MEN1KMT2APKMALDH1A1MAPT
SCHEMBL13850428 0.88 KCNA5 (0.37) MEN1KMT2APKMALDH1A1MAPT
SCHEMBL2913320 0.82 HTR1A (0.39) MEN1KMT2AALDH1A1MAPTGAA
SCHEMBL13850487 0.81 ALDH1A1 (0.41) MEN1KMT2AALDH1A1HTTGAA
SCHEMBL2915410 0.77 MEN1 (0.45) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL2909202 0.77 KCNA5 (0.36) MEN1KMT2AALDH1A1MAPTGAA
SCHEMBL13212951 0.75 HTR1A (0.38) MEN1KMT2AALDH1A1MAPTGAA
SCHEMBL2912440 0.75 HTR1A (0.41) MEN1KMT2AALDH1A1MAPTLMNA
SCHEMBL2914991 0.75 PPARA (0.41) KCNA5
SCHEMBL2914341 0.74 FFAR4 (0.39) MEN1KMT2AALDH1A1MAPTMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979355-B1 SPIRO IMIDAZOLE DERIVATIVES AS PPAR MODULATORS IRM LLC (BM) 2010-08-18 EP disclosed
US-20090137610-A1 SPIRO IMIDOZOLE DERIVATIVES AS PPAR MODULATORS IRM LLC (BM) 2009-05-28 US disclosed
US-20090137610-A1 SPIRO IMIDOZOLE DERIVATIVES AS PPAR MODULATORS IRM LLC (BM) 2009-05-28 US disclosed
EP-1979355-A1 SPIRO IMIDAZOLE DERIVATIVES AS PPAR MODULATORS IRM LLC (BM) 2008-10-15 EP disclosed
WO-2007087448-A1 SPIRO IMIDAZOLE DERIVATIVES AS PPAR MODULATORS IRM LLC (BM) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137610-A1 SPIRO IMIDOZOLE DERIVATIVES AS PPAR MODULATORS PPARD, PPARG, PPARA MEN1 4719/4885KMT2A 3750/4885PKM 492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.